Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters

Human Gene Therapy

Volumn 18, Issue 8, 2007, Pages 681-690

  Bortolanza, Sergia ^a   Alzuguren, Pilar ^a   Buñuales, Maria ^a   Qian, Cheng ^a   Prieto, Jesus ^a   Hernandez Alcoceba, Ruben ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC ADENOVIRUS;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PANCREAS CANCER; SYRIAN HAMSTER; TUMOR XENOGRAFT; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CELL LINE; CRICETINAE; FEMALE; HUMANS; MESOCRICETUS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; CRICETINAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5; MESOCRICETUS AURATUS; MURINAE;

EID: 34548473135     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.017     Document Type: Article

References (33)

1. AGHI, M., and MARTUZA, R.L. (2005). Oncolytic viral therapies: The clinical experience. Oncogene 24, 7802-7816.
2. CORBETT, T.H., GRISWOLD, D.P., Jr., ROBERTS, B.J., PECKHAM, J.C., and SCHABEL, F.M., Jr. (1975). Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogenstructure. Cancer Res. 35, 2434-2439.
3. DUNCAN, S.J., GORDON, F.C., GREGORY, D.W., MCPHIE, J.L., POSTLETHWAITE, R., WHITE, R., and WILLCOX, H.N. (1978). Infection of mouse liver by human adenovirus type 5. J. Gen. Virol. 40, 45-61.
4. ERILL, N., CUATRECASAS, M., SANCHO, F.J., FARRE, A., POUR, P.M., LLUIS, F., and CAPELLA, G. (1996). K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines. Am. J. Pathol. 149, 1333-1339.
5. GANLY, I., MAUTNER, V., and BALMAIN, A. (2000). Productive replication of human adenoviruses in mouse epidermal cells. J. Virol. 74, 2895-2899.
6. HABIB, N., SALAMA, H., ABD EL LATIF ABU MEDIAN, A., ISAC ANIS, I., ABD AL AZIZ, R.A., SARRAF, C., MITRY, R., HAVLIK, R., SETH, P., HARTWIGSEN, J., BHUSHAN, R., NICHOLLS, J., and JENSEN, S. (2002). Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Ther. 9, 254-259.
7. HALLDEN, G., HILL, R., WANG, Y., ANAND, A., LIU, T.C., LEMOINE, N.R., FRANCIS, J., HAWKINS, L., and KIRN, D. (2003). Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy. Mol. Ther. 8, 412-424.
8. HECHT, J.R., BEDFORD, R., ABBRUZZESE, J.L., LAHOTI, S., REID, T.R., SOETIKNO, R.M., KIRN, D.H., and FREEMAN, S.M. (2003). A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin. Cancer Res. 9, 555-561.
9. HERNANDEZ-ALCOCEBA, R., PIHALJA, M., WICHA, M.S., and CLARKE, M.F. (2000). A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors. Hum. Gene Ther. 11, 2009-2024.
10. HJORTH, R.N., BONDE, G.M., PIERZCHALA, W.A., VERNON, S.K., WIENER, F.P., LEVNER, M.H., LUBECK, M.D., and HUNG, P.P. (1988). A new hamster model for adenoviral vaccination. Arch. Virol. 100, 279-283.
11. JOGLER, C., HOFFMANN, D., THEEGARTEN, D., GRUNWALD, T., UBERLA, K., and WILDNER, O. (2006). Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species. J. Virol. 80, 3549-3558.
12. KASUYA, H., TAKEDA, S., NOMOTO, S., and NAKAO, A. (2005). The potential of oncolytic virus therapy for pancreatic cancer. Cancer Gene Ther. 12, 725-736.
13. KO, D., HAWKINS, L., and YU, D.C. (2005). Development of transcriptionally regulated oncolytic adenoviruses. Oncogene 24, 7763-7774.
14. LI, D., XIE, K., WOLFF, R., and ABBRUZZESE, J.L. (2004). Pancreatic cancer. Lancet 363, 1049-1057.
15. MAKOWER, D., ROZENBLIT, A., KAUFMAN, H., EDELMAN, M., LANE, M.E., ZWIEBEL, J., HAYNES, H., and WADLER, S. (2003). Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clin. Cancer Res. 9, 693-702.
16. MAZZOLINI, G., QIAN, C., NARVAIZA, I., BARAJAS, M., BORRAS-CUESTA, F., XIE, X., DUARTE, M., MELERO, I., and PRIETO, J. (2000). Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level. Hum. Gene Ther. 11, 113-125.
17. MORIOKA, C.Y., SAITO, S., KITA, K., and WATANABE, A. (2000a). Curative resection of orthotopically implanted pancreatic cancer in Syrian golden hamsters. Int. J. Pancreatol. 28, 207-213.
18. MORIOKA, C.Y., SAITO, S., OHZAWA, K., and WATANABE, A. (2000b). Homologous orthotopic implantation models of pancreatic ductal cancer in Syrian golden hamsters: Which is better for metastasis research - cell implantation or tissue implantation? Pancreas 20, 152-157.
19. MORIOKA, C.Y., SAITO, S., and WATANABE, A. (2000c). "Return trip" metastases from the liver to the pancreas in Syrian golden hamsters. In Vivo 14, 467-469.
20. INK4b cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells. Gene 278, 235-243.
21. OONUMA, M., SUNAMURA, M., MOTOI, F., FUKUYAMA, S., SHIMAMURA, H., YAMAUCHI, J., SHIBUYA, K., EGAWA, S., HAMADA, H., TAKEDA, K., and MATSUNO, S. (2002). Gene therapy for intraperitoneally disseminated pancreatic cancers by Escherichia coli uracil phosphoribosyltransferase (UPRT) gene mediated by restricted replication-competent adenoviral vectors. Int. J. Cancer 102, 51-59.
22. PACINI, D.L., DUBOVI, E.J., and CLYDE, W.A., Jr. (1984). A new animal model for human respiratory tract disease due to adenovirus. J. Infect. Dis. 150, 92-97.
23. PARATO, K.A., SENGER, D., FORSYTH, P.A., and BELL, J.C. (2005). Recent progress in the battle between oncolytic viruses and tumours. Nat. Rev. Cancer 5, 965-976.
24. REIN, D.T., BREIDENBACH, M., and CURIEL, D.T. (2006). Current developments in adenovirus-based cancer gene therapy. Future Oncol. 2, 137-143.
25. SAITO, S., NISHIMURA, N., KUBOTA, Y., YAMAZAKI, K., SHIBUYA, T., and SASAKI, H. (1988). Establishment and characterization of a cultured cell line derived from nitrosamine-induced pancreatic ductal adenocarcinoma in Syrian golden hamsters. Gastroenterol. Jpn. 23, 183-194.
26. TAKAHASHI, M., SATO, T., SAGAWA, T., LU, Y., SATO, Y., IYAMA, S., YAMADA, Y., FUKAURA, J., TAKAHASHI, S., MIYANISHI, K., YAMASHITA, T., SASAKI, K., KOGAWA, K., HAMADA, H., KATO, J., and NIITSU, Y. (2002). E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor. Mol. Ther. 5, 627-634.
27. THOMAS, M.A., SPENCER, J.F., LA REGINA, M.C., DHAR, D., TOLLEFSON, A.E., TOTH, K., and WOLD, W.S. (2006). Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. Cancer Res. 66, 1270-1276.
28. TORRES, J.M., ALONSO, C., ORTEGA, A., MITTAL, S., GRAHAM, F., and ENJUANES, L. (1996). Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. J. Virol. 70, 3770-3780.
29. TOTH, K., SPENCER, J.F., TOLLEFSON, A.E., KUPPUSWAMY, M., DORONIN, K., LICHTENSTEIN, D.L., LA REGINA, M.C., PRINCE, G.A., and WOLD, W.S. (2005). Cotton rat tumor model for the evaluation of oncolytic adenoviruses. Hum. Gene Ther. 16, 139-146.
30. TOWNSEND, C.M., Jr., FRANKLIN, R.B., GELDER, F.B., GLASS, E., and THOMPSON, J.C. (1982). Development of a transplantable model of pancreatic duct adenocarcinoma. Surgery 92, 72-78.
31. WANG, Y., HALLDEN, G., HILL, R., ANAND, A., LIU, T.C., FRANCIS, J., BROOKS, G., LEMOINE, N., and KIRN, D. (2003). E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models. Nat. Biotechnol. 21, 1328-1335.
32. WILDNER, O., and MORRIS, J.C. (2002). Subcutaneous administration of a replication-competent adenovirus expressing HSV-tk to cotton rats: Dissemination, persistence, shedding, and pathogenicity. Hum. Gene Ther. 13, 101-112.
33. YOUNG, L.S., SEARLE, P.F., ONION, D., and MAUTNER, V. (2006). Viral gene therapy strategies: From basic science to clinical application. J. Pathol. 208, 299-318.